Ny leverantör hjälper oss bredda vårt sortiment

Tillsammans med vår leverantör Meister kan vi nu presentera och bredda vårt sortiment av flödesprodukter.

Scientific Solutions

“Together Stockholm-Uppsala and Medicon Valley can make Scandinavia a leading life science region”

“Denmark, Sweden, Norway and Finland all have national life science strategies, but the Swedish strategy is the only one explicitly emphasizing the Nordic dimen...

17 nätdroger narkotikaklassas

Vissa har orsakat dödsfall.

Pfizer påbörjar vaccinprogram mot influensa

Pfizer har rekryterat den första patienten för sin mRNA-baserade vaccinstudie mot influensa.

Failed to read the fine print – lost his life’s work

A celebrated CEO and co-founder of a pioneering lab company one moment – the next, fired, kicked out and written out of the company’s history. This is the story...

“What is important is to create an overview and understanding from different perspectives”

Scientist Jochen Schwenk analyses blood proteins using proteomics to improve our understanding of disease and health. This year, he is moderating the Lab & Diag...

Hett i tanken

Synglas från KSR Kuebler förenklar nivåövervakningen

Business Sweden: “Companies have a lot to offer in data-driven precision medicine”

Data-driven precision medicine can potentially solve major healthcare problems, states Business Sweden in a new report on the subject.

Novo Nordisks insulin gav bättre kontroll

Signifikant bättre blodsockerkontroll och lägre risk för hypoglykemi med bolagets långverkande insulin jämfört med konkurrerande preparat. Detta visar data från...

Biomarkörer kan avgöra svårighetsgrad av astma

Forskare från Karolinska institutet har genom att studera urinprov kunnat diagnosticera svår astma.

New report: Fewer PhDs in life sciences

A new report from Vinnova suggests that competency returns in the life science sector are declining.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Gileads besked – så mycket kommer remdesivir kosta

Priset för att behandla en covid-19-patient med remdesvir landar på 21 800 kronor. – Det är lite lägre än vad jag trodde, säger Anders Sönnerborg till Life Science Sweden.

Så tog vi oss in på USA-marknaden

Här delar Nikolaj Sørensen, vd och koncernchef, med sig av Orexos tuffa resa att lansera läkemedel i USA.

Bayer skär ned kraftigt

Den tyska kemijätten ska omstrukturera läkemedelsforskningen och konsumenthälsodelen av bolaget och skär ned med 900 tjänster.

Nobel Prize winner Torsten Wiesel turns 100: “Old men like me should use their experience to help the young”

In 1955, a young Torsten Wiesel jumped on a boat to the US and embarked on a fabulous career as a neuroscientist, crowned with a Nobel Prize for his work. Now 1...

“We aim to be a start-up company with an academic spirit”

Chronic pain and Alzheimer’s are two diseases that plague many people worldwide and seem impossible to cure. However, Huddinge-based company Alzecure is working...

De tar plats i Sobis styrelse

David Allsop och Elisabeth Svanberg nya ledamöter i läkemedelsbolagets styrelse.

We will now publish more news in English – and offer yet another newsletter

Starting next week, Life Science Sweden will begin offering a newsletter entirely in English.

Now it’s settled: The International Vaccine Institute will be located in Stockholm

The International Vaccine Institute, IVI, is establishing itself outside South Korea for the first time. Last week, the Swedish Parliament ratified the agreemen...

Collaboration for a simpler production of gene therapies launched

A collaboration between universities and companies aims at providing better production methods for the development of gene therapies. The initiative is led by J...

The TFS family is growing

TFS HealthScience is a European based CRO company with broad expertise and experiences in the biotech and pharmaceutical sector. The company is growing and the ...

Ågerup ger bort rubbet

Skänker sin förmögenhet till utvecklingsprojekt i u-länder.